Ftse Mib
33.645,43
-0,27%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.197,99
6,90%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GeneDx Holdings Corporation (WGS) GeneDx Holdings Corporation (WGS) Notizie

GeneDx Holdings Corporation

WGS
19,66
0,16 (0,82%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:33:21
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202422:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23/4/202414:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
04/4/202422:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14/3/202413:30GLOBEGeneDx to Present Data at the 2024 American College of..
05/3/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
23/2/202422:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202422:28EDGAR2Form 8-K - Current report
20/2/202422:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
01/2/202422:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
24/1/202422:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
23/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:58EDGAR2Form 8-K - Current report
08/1/202414:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
04/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202303:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
28/11/202322:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
20/11/202322:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
17/11/202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
03/11/202321:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202321:33EDGAR2Form 8-K - Current report
30/10/202321:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
23/10/202323:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202322:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
03/10/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202322:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
20/9/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202300:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202314:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
06/9/202322:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202314:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
21/8/202313:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
09/8/202302:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
08/8/202322:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202322:13EDGAR2Form 8-K - Current report
08/8/202322:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
07/8/202314:00GLOBEPacBio and GeneDx Launch Research Collaboration with the..
27/7/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202323:04EDGAR2Form 8-K - Current report
22/7/202303:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202313:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..
Apertura: 19,47 Min: 19,09 Max: 21,71
Chiusura: 19,50

La tua Cronologia

NASDAQ
WGS
GeneDx
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network